NCT04426773

Brief Summary

This study is designed to find Electroencephalogram (EEG) biomarkers to predict transcranial direct current stimulation (tDCS) response in obsessive-compulsive disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
20 days until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

4.8 years

First QC Date

June 8, 2020

Last Update Submit

May 12, 2025

Conditions

Keywords

transcranial direct current stimulation

Outcome Measures

Primary Outcomes (3)

  • Change in symptom improvement assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)

    It assesses the severity of OCD symptoms. The Y-BOCS scale ranges from 0 to 40, with 0 being no symptoms and 40 being severe.The responder on Y-BOCS is defined as a Y-BOCS decrease at least 35% from the baseline at post-treatment.

    Up to 3 months

  • Change in long-interval intracortical inhibition (LICI) and short interval intracortical inhibition (SICI) measured by TMS-EEG

    LICI and SICI are TMS-EEG paradigm to assess the extent of cortical inhibition. LICI and SICI will be measured using single and paired TMS pulses applied to the OFC. LICI and SICI will be compared between before and after treatment.

    Up to 2 weeks

  • EEG biomarkers as predictors of response to tDCS

    LICI and SICI measured by TMS-EEG and resting state EEG will be performed to investigate predictors of response to tDCS in OCD patients.

    baseline

Secondary Outcomes (5)

  • Change in Obsessive Compulsive Inventory-Revised(OCI-R)

    Up to 3 months

  • Change in The Beck Depression Inventory(BDI)

    Up to 3 months

  • Change in The Beck Anxiety Inventory (BAI)

    Up to 3 months

  • Change in Pittsburgh sleep quality index(PSQI)

    Up to 3 months

  • Change in Side-effect questionnaire

    Up to 3 months

Study Arms (1)

tDCS treatment

EXPERIMENTAL

Cathode transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.

Device: High-Definition transcranial direct current stimulation

Interventions

The tDCS device will deliver a direct current of 1.5mA for 20 minutes. Cathode electrode will be localized in front of the OFC on the Fp2 point according to the EEG international reference. Four anode electrodes will be placed around FP2 (i.e. Fpz, AFz, AF4, AF8).

tDCS treatment

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age: 18-50 years old;
  • DSM-5 criteria for OCD;
  • Y-BOCS total score \> or = 16
  • \>or=9 years education

You may not qualify if:

  • any additional current psychiatric comorbidity
  • The inability to receive tDCS because of metallic implants, or history of seizures,history of head injury, or history of neurosurgery.
  • Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
  • Any current significant medical condition.
  • serious suicide risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Zhen Wang, PhD,MD

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice-president

Study Record Dates

First Submitted

June 8, 2020

First Posted

June 11, 2020

Study Start

July 1, 2020

Primary Completion

April 30, 2025

Study Completion

May 1, 2025

Last Updated

May 15, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations